These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19573811)

  • 1. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
    McGillicuddy LT; Fromm JA; Hollstein PE; Kubek S; Beroukhim R; De Raedt T; Johnson BW; Williams SM; Nghiemphu P; Liau LM; Cloughesy TF; Mischel PS; Parret A; Seiler J; Moldenhauer G; Scheffzek K; Stemmer-Rachamimov AO; Sawyers CL; Brennan C; Messiaen L; Mellinghoff IK; Cichowski K
    Cancer Cell; 2009 Jul; 16(1):44-54. PubMed ID: 19573811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the Ubiquitin Ligase complex that regulates the NF1 tumor suppressor and Ras.
    Hollstein PE; Cichowski K
    Cancer Discov; 2013 Aug; 3(8):880-93. PubMed ID: 23661552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.
    Cichowski K; Santiago S; Jardim M; Johnson BW; Jacks T
    Genes Dev; 2003 Feb; 17(4):449-54. PubMed ID: 12600938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
    Dasgupta B; Li W; Perry A; Gutmann DH
    Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NF1 tumor suppressor critically regulates TSC2 and mTOR.
    Johannessen CM; Reczek EE; James MF; Brems H; Legius E; Cichowski K
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8573-8. PubMed ID: 15937108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
    Anastasaki C; Gutmann DH
    Hum Mol Genet; 2014 Dec; 23(25):6712-21. PubMed ID: 25070947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
    Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
    Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
    Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
    Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
    Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
    J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.
    Brundage ME; Tandon P; Eaves DW; Williams JP; Miller SJ; Hennigan RH; Jegga A; Cripe TP; Ratner N
    Oncogene; 2014 Dec; 33(49):5626-36. PubMed ID: 24509877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.
    Stansfield BK; Bessler WK; Mali R; Mund JA; Downing BD; Kapur R; Ingram DA
    Am J Pathol; 2014 Jan; 184(1):79-85. PubMed ID: 24211110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells.
    Zhou X; Kim SH; Shen L; Lee HJ; Chen C
    Cell Cycle; 2014; 13(15):2340-8. PubMed ID: 25483185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
    Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.